|
|
Article: Celera Diagnostics Identifies Gene Variant Associated with Increased Risk for Rheumatoid Arthritis; Link between RA Risk and PTPN22 Described at EULAR Meeting.
- Article from:
- Business Wire
- Article date:
- June 10, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
BIOWIRE2K
Annual European Congress of Rheumatology (EULAR)
ALAMEDA, Calif. & BERLIN--(BUSINESS WIRE)--June 10, 2004
Celera Diagnostics today presented data linking variation in the gene PTPN22 to a two-fold increase in risk for rheumatoid arthritis (RA). In a scientific session at the Annual European Congress of Rheumatology (EULAR) in Berlin, Ann Begovich, Ph.D., Director, Inflammation at Celera Diagnostics, described the study, in which Celera Diagnostics and it collaborators at the North American Rheumatoid Arthritis Consortium (NARAC) and Genomics Collaborative, Inc. discovered and replicated ...